These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 38638375)

  • 1. Role of Fibrinogen-like Protein 1 in Tumor Recurrence Following Hepatectomy.
    Shafieizadeh Z; Shafieizadeh Z; Davoudi M; Afrisham R; Miao X
    J Clin Transl Hepatol; 2024 Apr; 12(4):406-415. PubMed ID: 38638375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen-Like Protein 1 Modulates Sorafenib Resistance in Human Hepatocellular Carcinoma Cells.
    Son Y; Shin NR; Kim SH; Park SC; Lee HJ
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted disruption of fibrinogen like protein-1 accelerates hepatocellular carcinoma development.
    Nayeb-Hashemi H; Desai A; Demchev V; Bronson RT; Hornick JL; Cohen DE; Ukomadu C
    Biochem Biophys Res Commun; 2015 Sep; 465(2):167-73. PubMed ID: 26225745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation of fibrinogen-like protein-1 expression with the progression and prognosis of hepatocellular carcinoma.
    Hua N; Chen A; Yang C; Dong H; He X; Ru G; Tong X; Zhou F; Wang S
    Mol Biol Rep; 2022 Aug; 49(8):7911-7919. PubMed ID: 35776395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen-like protein 1, a hepatocyte derived protein is an acute phase reactant.
    Liu Z; Ukomadu C
    Biochem Biophys Res Commun; 2008 Jan; 365(4):729-34. PubMed ID: 18039467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of the hepatokine, fibrinogen-like protein 1 in liver diseases, metabolic disorders and cancer: The need to harness its full potential.
    Liu XH; Qi LW; Alolga RN; Liu Q
    Int J Biol Sci; 2022; 18(1):292-300. PubMed ID: 34975333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted deletion of fibrinogen like protein 1 reveals a novel role in energy substrate utilization.
    Demchev V; Malana G; Vangala D; Stoll J; Desai A; Kang HW; Li Y; Nayeb-Hashemi H; Niepel M; Cohen DE; Ukomadu C
    PLoS One; 2013; 8(3):e58084. PubMed ID: 23483972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGL1 and FGL2: emerging regulators of liver health and disease.
    Chen J; Wu L; Li Y
    Biomark Res; 2024 May; 12(1):53. PubMed ID: 38816776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen-like protein 1 (FGL1): the next immune checkpoint target.
    Qian W; Zhao M; Wang R; Li H
    J Hematol Oncol; 2021 Sep; 14(1):147. PubMed ID: 34526102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Fibrinogen-Like 1 as a Potential Biomarker for Radiation-Induced Liver Injury.
    Han NK; Jung MG; Jeong YJ; Son Y; Han SC; Park S; Lim YB; Lee YJ; Kim SH; Park SC; Lee HJ
    Cells; 2019 Sep; 8(9):. PubMed ID: 31489941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eicosapentaenoic Acid Inhibits
    Chiu CF; Hsu MI; Yeh HY; Park JM; Shen YS; Tung TH; Huang JJ; Wu HT; Huang SY
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33801246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancer.
    Li JJ; Wang JH; Tian T; Liu J; Zheng YQ; Mo HY; Sheng H; Chen YX; Wu QN; Han Y; Liao K; Pan YQ; Zeng ZL; Liu ZX; Yang W; Xu RH; Ju HQ
    Nat Commun; 2023 Oct; 14(1):6690. PubMed ID: 37872170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting fibrinogen-like protein 1 enhances immunotherapy in hepatocellular carcinoma.
    Lin M; He J; Zhang X; Sun X; Dong W; Zhang R; Xu Y; Lv L
    J Clin Invest; 2023 May; 133(9):. PubMed ID: 37115693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Serum FGL1 as Diagnostic Markers for HBV-Related Hepatocellular Carcinoma.
    Cai X; Tang D; Chen J; Li H; Zhang P
    Lab Med; 2023 May; 54(3):270-281. PubMed ID: 36219698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer.
    Sun C; Gao W; Liu J; Cheng H; Hao J
    Respir Res; 2020 Aug; 21(1):210. PubMed ID: 32778129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and clinical significance of LAG-3, FGL1, PD-L1 and CD8
    Guo M; Yuan F; Qi F; Sun J; Rao Q; Zhao Z; Huang P; Fang T; Yang B; Xia J
    J Transl Med; 2020 Aug; 18(1):306. PubMed ID: 32762721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen-like protein 1 promotes liver-resident memory T-cell exhaustion in hepatocellular carcinoma.
    Yang C; Qian Q; Zhao Y; Huang B; Chen R; Gong Q; Ji H; Wang C; Xia L; You Z; Zhang J; Chen X
    Front Immunol; 2023; 14():1112672. PubMed ID: 36993960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two fibrinogen-like proteins, FGL1 and FGL2 are disulfide-linked subunits of oligomers that specifically bind nonviable spermatozoa.
    Nagdas SK; Winfrey VP; Olson GE
    Int J Biochem Cell Biol; 2016 Nov; 80():163-172. PubMed ID: 27732889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1-FGL1-MYH9 axis.
    Tang XY; Xiong YL; Zhao YB; Yang J; Shi AP; Zheng KF; Liu YJ; Shu C; Jiang T; Ma N; Zhao JB
    Front Immunol; 2022; 13():1014053. PubMed ID: 36268014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGL1 as a Novel Mediator and Biomarker of Malignant Progression in Clear Cell Renal Cell Carcinoma.
    Lv Z; Cui B; Huang X; Feng HY; Wang T; Wang HF; Xuan YD; Li HZ; Ma X; Huang Y; Zhang X
    Front Oncol; 2021; 11():756843. PubMed ID: 34956878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.